Chondrogenic differentiation of human adipose‑derived stem cells using microcarrier and bioreactor combination technique.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

The aim of the current study was to explore the application of microcarrier technology in the rapid amplification and chondrogenic differentiation of human adipose‑derived stem cells (ADSCs) in a rotating bioreactor. Human ADSCs were cultivated with Cytodex 3 microcarriers in a rotary cell culture system (RCCS), and using inverted and scanning electron microscopes, the ADSCs were observed on the surface of the microcarriers. The harvested ADSCs were stained with safranin‑O or toluidine blue histochemical stains, and type II collagen immunohistochemical stain. ADSCs were adherent to the surface of Cytodex 3 microcarriers by 24 h. They became short and spindle‑shaped, and as time progressed, the adherence of the cells to the microcarriers gradually improved. By the end of the culture period, the cell densities were ~19 times that of the initial cell density. The harvested cells on microcarriers were safranin-O and toluidine blue staining and collagen Ⅱ‑positive staining, which were stronger than the control group. The application of microcarrier technology is able to rapidly amplify human ADSC proliferation and successfully implement chondrogenic differentiation in vitro.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.